Elucent receives FDA breakthrough designation for EnVisio X1. Read our press release to learn more.

Technology
Who We Serve
About Us
News
Contact Us
Get a Demo

EnVisio Education Summit

Kevin Sandness

January 30, 2025

Previous: Trinity Capital Inc. Provides $30 Million in Growth Capital to Elucent Medical

Next: Society of Thoracic Surgeons

Home
Technology
Who We Serve
About Us
News
Careers

Case Studies
Elucent.edu
Product IFUS

© 2025 Elucent Medical

Privacy Policy Page